S
higa-like toxins (Stx1 and Stx2) produced by certain strains of Escherichia coli are potent ribosomeinactivating proteins (RIPs) 1 responsible for outbreaks of foodborne disease with significant morbidity and mortality 2 . Ricin, produced by the castor plant Ricinus communis, is another potent RIP that has been used for both bioterrorism and the targeted killing of cancerous cells 3 . No US Food and Drug Administrationapproved vaccines or therapeutics currently exist to protect against ricin, Shiga-like toxins, or other RIPs.
Small-molecule inhibitors of ricin and Shiga-like toxins have been sought as potential therapeutics for preor post-exposure prophylaxis against RIP poisoning. Two small-molecule structures (Retro-1 and Retro-2; Figure 1 ) have been discovered with high-throughput screening for their cell protection against RIPs 4 . Of great significance, Retro-2 at a concentration of 200 mg/kg demonstrated full protection of mice against a dose of ricin that killed 90% of an unprotected control mouse population 4 . Using the doorstop approach in search of small-molecule RIP inhibitors that target the catalytic domain of the toxin 5 , we synthesized Retro-2 as a benchmark and found that the reported achiral Retro-2 structure 4 is unstable. Herein, we report our chemical syntheses and cell-based assays showing that the chemical structure of the compound that conferred cell protection activity against RIPs is Retro-2 cycl (a racemic mixture; Figure 1 ). This raises a call for attention to Retro-2 cycl as a promising RIP inhibitor and for chemical characterization of small molecules to be used in biological studies.
Results
Chemical structure analysis of Retro-2. Reaction of 2-amino-N-phenylbenzamide with 4-chlorobenzaldehyde in ethanol at room temperature with a catalytic amount of p-toluenesulfonic acid reportedly yielded IA4CL (a close analog of Retro-2; Figure 1 ) 6 . No synthetic procedure has been reported for the commercially available Retro-2, and the vendor ChemBridge (San Diego, CA) provided Retro-2 for the reported biological study 4 . We obtained Retro-2 cycl in 60% yield using the same reaction conditions reported for the synthesis of IA4CL, and found that these reaction conditions actually produced A4CL (a close analog of Retro-2 cycl ; Figure 1 ). Evidence that Retro-2 cycl rather than Retro-2 was the reaction product is found in the chemical shifts of two aliphatic carbon atoms (71.38 and 15.63 ppm) in the carbon NMR spectrum of Retro-2 cycl because Retro-2 and Retro-2 cycl have one and two aliphatic carbon atoms, respectively. We also found that reacting 2-amino-N-phenylbenzamide with 5-methylthiophene-2-carbaldehyde in acetic acid at room temperature produced Retro-2 cycl exclusively in 88% yield. Interestingly, we found that stirring the two reactants in methanol for 1.5 hours at room temperature yielded Retro-2 cycl and Retro-2. The latter has a chemical shift of only one aliphatic carbon atom (16.49 ppm) in the carbon NMR spectrum. Our proton NMR spectroscopic study showed that Retro-2 spontaneously converted to Retro-2 cycl in neat deuterated methanol over a period of 144 hours, as indicated in Figure 2 by the gradual disappearance of the chemical shifts for the imine proton (8.71 ppm) and the methyl proton (2.59 ppm) of Retro-2 and the gradual and simultaneous appearance of the chemical shifts for the proton at the chiral center (6.26 ppm) and the methyl proton (2.34 ppm) of Retro-2 cycl . The half-life of Retro-2 is ,24 hours in neat deuterated methanol ( Figure 2 ). In the presence of a catalytic amount of acid, however, the conversion of Retro-2 to Retro-2 cycl was completed within ,30 minutes.
More conclusively, we purchased Retro-2-listed as 2-{[(5-methyl-2-thienyl)methylene]amino}-N-phenylbenzamide with ID 5374762-from ChemBridge and found that the proton and carbon NMR spectra of the product we received were identical to those of Retro-2 cycl . These results indicate that Retro-2 is unstable and spontaneously converts to Retro-2 cycl .
Cell-based assays of retro-2 cycl and A4CL. To investigate whether Retro-2 cycl is the actual chemical structure associated with cell protection against RIPs, we tested the cell-protection activities of Retro-2 cycl and A4CL using a [ 35 S]-Met-incorporation-based protein synthesis assay in Vero cells. As shown in Figure 3 , the presence of 20 mM Retro-2 cycl moved the dose-response curve of protein synthesis in the presence of ricin or Stx2 to increased Met incorporation, indicating cell protection by Retro-2 cycl against ricin and Stx2. A4CL also showed cell protection against both toxins but was slightly less effective than Retro-2 cycl .
Discussion
The conversion of imines to 2,3-dihydroquinazolin-4(1H)-ones is well established in the literature [7] [8] [9] [10] [11] . The erroneous characterization of IA4CL rather than A4CL as the product of the reaction of 2-amino-N-phenylbenzamide with 4-chlorobenzaldehyde in ethanol with a catalytic amount of p-toluenesulfonic acid was, in our view, probably due to the omission of the crucial carbon NMR spectrum 6 . The abundant literature information on 2,3-dihydroquinazolin-4(1H)-one synthesis and our synthetic work described above show unequivocally that Retro-2 is unstable and spontaneously converts to Retro-2 cycl . Given that the NMR spectra of Retro-2 from ChemBridge, which provided Retro-2 for the reported biological studies 4 , are identical to those of Retro-2 cycl and that Retro-2 cycl and its structurally similar analog A4CL protect cells against ricin and Stx2, it is conceivable that Retro-2 cycl -which is a racemate-is the compound responsible for the reported biological activities 4 . In this context, we measured the optical rotations of Retro-2 from ChemBridge and Retro-2 cycl and found both to be zero. These results further support our assertion that a racemic mixture of Retro-2 cycl produced the reported biological data 4 . We have previously reported caveats for the use of chemical screens for potential drug leads 5, 12 . In a reported virtual screen for farnesyltransferase inhibitors 12 , we found that 6 of 27 compounds purchased from chemical vendors had serious chemical identity or purity issues. In another study of RIP inhibitors 5 , spectroscopic analyses required to confirm the stereochemistry of two chemicals revealed that the stereochemistry of one had been assigned incorrectly by the vendor. In the Retro-2 report 4 , of two promising chemical structures discovered with high-throughput screening, one appears to have been incompletely characterized by the chemical vendor. These repeated problems raise concerns and call for chemical characterization of leads identified from high-throughput screens.
Methods
General description of chemical synthesis. All commercially available reagents were used as received. 1 H NMR (400 MHz) and 13 C NMR (100 MHz) spectra were recorded on a Mercury 400 spectrometer from Varian (Palo Alto, CA). Chemical shifts are reported in ppm using the solvent peak as an internal standard. Data are reported as follows: chemical shift, multiplicity (s 5 singlet, d 5 doublet, t 5 triplet, and m 5 multiplet), coupling constant, and integration. Low-resolution mass spectra (LRMS) were recorded using either a Hewlett Packard 5973 Mass Spectrometer with SIS Direct Insertion Probe (Palo Alto, CA) or a Waters ZQ/EMD 1000 Mass Spectrometer (Milford, MA). High-resolution mass spectra (HRMS) were obtained on a Bruker BioTOF II ESI. IR spectra were obtained on a ThermoNicolet Avatar 370 FT-IR (Waltham, MA) using a KBr pellet. A Biotage SP-1 (Charlotte, NC) was used for medium pressure liquid chromatography (MPLC) purification using silica gel as the packing material.
Synthesis of (E)-2-(((5-methylthiophen-2-yl)methylene)amino)-Nphenylbenzamide (Retro-2).
To a stirred solution of 2-amino-N-phenylbenzamide (0.42 g, 2.00 mmol) in methanol (6 mL) at room temperature was added 5-methylthiophene-2-cabaldehyde (214 mL, 2.00 mmol). After 1.5 hours of stirring, the reaction mixture was chilled to 220uC for 1 hour. The resulting yellow short needles were collected via filtration, washed with methanol, and dried under high vacuum to give 0.35 g of yellow powder determined to be a 151 mixture of Retro-2 and Retro-2 cycl using 1 H NMR. The filtrate and washings were combined, concentrated in vacuo, purified with MPLC (silica gel, 100% hexanes to 30% EtOAc-hexanes) to give Retro-2 (0.16 g) as yellow viscous syrup and 0.11 g of a 151 mixture of Retro-2 and Retro-2 cycl . The estimated yields of Retro-2 and Retro-2 cycl were 0.39 g (61%) and 0.23 g (36%), respectively. Because Retro-2 (oil) was cyclized spontaneously to Retro-2 cycl (solid), the spectral data were collected within 30 minutes after MPLC purification. Synthesis of 2- (5-methylthiophen-2-yl)-3-phenyl-2,3-dihydroquinazolin-4(1H) one (Retro-2 cycl ). Method 1: To a stirred solution of 2-amino-N-phenylbenzamide (0.10 g, 0.48 mmol) and a few crystals of p-toluenesulfonic acid hydrate in ethanol (3 mL) was added 5-methylthiophene-2-cabaldehyde (56.5 mL, 0.52 mmol) at room temperature. Yellow precipitates appeared in 10 minutes; the color disappeared in 30 minutes. The precipitates were collected via filtration, and the filter cake was washed with ethanol and dried under high vacuum to give 0.093 g (60%) of Retro-2 cycl as a grey powder. Method 2: To a stirred solution of 2-amino-N-phenylbenzamide (0.21 g, 1.00 mmol) in acetic acid (3 mL) at room temperature was added 5-methylthiophene-2-cabaldehyde (107 mL, 1.00 mmol). Thin-layer chromatography showed completion of the reaction in 20 minutes. The solvent was removed in vacuo, and the crude product was purified with MPLC (silica gel, 100% hexanes to 30% EtOAc-hexanes) to give 0.28 g (88%) of Retro-2 cycl as a pale yellow solid. The spectral data of Retro-2 cycl prepared using methods 1 and 2 were identical. mp 152-154uC; 1 4 cells/mL in the same medium, and 0.5 mL of the medium was dispensed into 24-well plates. After 24 hours at 37uC and 5% CO 2 , the medium was changed to Dulbecco's modified Eagle medium without Met, Gln, or fetal calf serum and equilibrated for 1 hour. An inhibitor solution with a final dimethyl sulfoxide concentration of 0.5% was added to the medium at 25 hours. Ricin or Stx2 was added after 26 hours at varied concentrations. 35 S]-Met incorporation was terminated 30 minutes after the Met addition via medium removal and addition of 150 mL of 0.2 M KOH to dissolve cells, as described elsewhere 13 . Proteins were precipitated with 10% trichloroacetic acid, harvested on glass fiber filters, and counted. The control incorporation was determined after treatment with 0.5% dimethyl sulfoxide alone. Ricin was purchased from Vector Laboratories (Burlingame, CA). Stx2 was provided by the Phoenix Laboratory (Tufts-NEMC Microbial Products & Services Facility).
